Abiopharma

BIOFRONTERA INC. IS NEGOTIATING FUNDAMENTAL CHANGES TO ITS COOPERATION WITH BIOFRONTERA AG

What Happened to the Nintendo Switch Version of Genshin Impact?

Genshin Impact Patch 5.7 “A Space and Time for You” – Coming June 18, 2025

Nintendo Switch 2 Smashes Records With 3.5 Million+ Units Sold in First 4 Days

Superman (2025): Final Trailer, Release Date Set, and Ticket Sales Begin

What Is Screen Tearing and How Do You Fix It?

Nuvation Bio Inc. - U.S. Food and Drug Administration Approves Nuvation Bio’s IBTROZI™ (taletrectinib), a Next-Generation Oral Treatment for Advanced ROS1-Positive Non-Small Cell Lung Cancer

Grifols successfully completes Biotest delisting

Enanta Pharmaceuticals’ Partner AbbVie Receives U.S. FDA Approval of an Expanded Indication for MAVYRET® (glecaprevir/pibrentasvir) as the First and Only Treatment for People with Acute Hepatitis C Virus

U.S. FDA Approves Expanded Indication for AbbVies MAVYRET® (Glecaprevir/Pibrentasvir) as First and Only Treatment for People with Acute Hepatitis C Virus